_id
69105cddccc777a4e85d5882
Ticker
DRMAW
Name
Dermata Therapeutics Inc. Warrant
Exchange
NASDAQ
Address
3525 Del Mar Heights Rd., San Diego, CA, United States, 92130
Country
USA
Sector
Industry
Currency
USD
Website
https://www.dermatarx.com
Description
Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications. Its lead product candidate is XYNGARI, which is in Phase 3 clinical studies for the treatment of moderate-to-severe acne, as well as completed Phase 1b proof of concept (POC) trial for mild-to-moderate psoriasis. The company is also developing DMT410 that has completed Phase 1b POC trials for the treatment of axillary hyperhidrosis and aesthetic skin conditions. It has a clinical trial collaboration agreement with Revance Therapeutics, Inc. to conduct a multi-center clinical trial to evaluate the topical application of XYNGARI with DAXXIFY, Revance's botulinum toxin type A. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Last Close
0.022
Volume
3070
Current Price
0.0176
Change
0.0004
Last Updated
2026-01-02T12:48:24.065Z
Image
data:image/webp;base64,UklGRsAAAABXRUJQVlA4ILQAAADwBwCdASpAAEAAPqFGm0mmJCKhOfdoAMAUCWgAzb4g/metG8U3gIv/2wLf/AW7WXlpYIgfs4flEPPGWmEMFJ7zOnYjlWPI1EAA/tLGP2w4lSVofiO5ADuT1qgPqlYLlMZFLDcJmYSQBAM9gb1WyMb+TqBsggGh1cGwdxyjsqXTm/qHgx42Dnlb+0gHPVQ5z92a4kqFI6O7dZPvftAyI2bJPt+wTA6Gr+kLjteeRLzAmsAAAAA=
Ipo Date
2021-08-13T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.974
Sentiment Sources
1
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
1760671
Operating Income
-1760671
Interest Expense
-
Pretax Income
-1691989
Net Income
-1691989
Eps
-1.6483778667786375
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-1691989
Operating Margin
-
Total Other Income Expense Net
68682
Cash
4664127
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
5071410
Property Plant Equipment
-
Total Assets
5071410
Payables
453427
Short Term Debt
-
Long Term Debt
-
Total Liabilities
1111308
Equity
3960102
Bs_currency_symbol
USD
Depreciation
-
Change In Working Capital
-149667
Cash From Operations
-1803815
Capital Expenditures
5
Cash From Investing
-
Cash From Financing
-12988
Net Change In Cash
-1816803
Cf_currency_symbol
USD
PE
-
PB
0.004561913607275773
ROE
-42.725894434032256
ROA
-33.36328555569359
FCF
-1803820
Fcf Percent
-
Piotroski FScore
0
Health Score
41
Deep Value Investing Score
5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
3.5
Net Net Investing Score
2
Quality Investing Score
3
Value Investing Score
7
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
1760671
Quarters > 0 > income Statement > operating Income
-1760671
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-1691989
Quarters > 0 > income Statement > net Income
-1691989
Quarters > 0 > income Statement > eps
-1.6483778667786375
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1026457
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-1691989
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
68682
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
4664127
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
5071410
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
5071410
Quarters > 0 > balance Sheet > payables
453427
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1111308
Quarters > 0 > balance Sheet > equity
3960102
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-1691989
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-149667
Quarters > 0 > cash Flow > cash From Operations
-1803815
Quarters > 0 > cash Flow > capital Expenditures
5
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-12988
Quarters > 0 > cash Flow > net Change In Cash
-1816803
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-1.6483778667786375
Quarters > 0 > ratios > PB
0.004561913607275773
Quarters > 0 > ratios > ROE
-42.725894434032256
Quarters > 0 > ratios > ROA
-33.36328555569359
Quarters > 0 > ratios > FCF
-1803820
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
41
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
1772731
Quarters > 1 > income Statement > operating Income
-1772731
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-1701093
Quarters > 1 > income Statement > net Income
-1701093
Quarters > 1 > income Statement > eps
-1.6571681022809415
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1026506
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-1701093
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
71638
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
6480930
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
6480930
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
6640516
Quarters > 1 > balance Sheet > payables
413687
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1026265
Quarters > 1 > balance Sheet > equity
5614251
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-1701093
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-1028621
Quarters > 1 > cash Flow > cash From Operations
-2690481
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-547857
Quarters > 1 > cash Flow > net Change In Cash
-3238338
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-1.6571681022809415
Quarters > 1 > ratios > PB
0.003217972548787007
Quarters > 1 > ratios > ROE
-30.29955376059959
Quarters > 1 > ratios > ROA
-25.616879772595986
Quarters > 1 > ratios > FCF
-2690481
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
41
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
2339803
Quarters > 2 > income Statement > operating Income
-2339803
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-2303587
Quarters > 2 > income Statement > net Income
-2303587
Quarters > 2 > income Statement > eps
-4.468645974781765
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
515500
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-2303587
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
36216
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
9719268
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
10005007
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
10005007
Quarters > 2 > balance Sheet > payables
1395313
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2703785
Quarters > 2 > balance Sheet > equity
7301222
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-2303587
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
332332
Quarters > 2 > cash Flow > cash From Operations
-1934066
Quarters > 2 > cash Flow > capital Expenditures
4
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
8491764
Quarters > 2 > cash Flow > net Change In Cash
6557698
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-4.468645974781765
Quarters > 2 > ratios > PB
0.0012426413003193166
Quarters > 2 > ratios > ROE
-31.550704799826658
Quarters > 2 > ratios > ROA
-23.02434171210475
Quarters > 2 > ratios > FCF
-1934070
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
3200288
Quarters > 3 > income Statement > operating Income
-3200288
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-3150938
Quarters > 3 > income Statement > net Income
-3150938
Quarters > 3 > income Statement > eps
-20.26326688102894
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
155500
Quarters > 3 > income Statement > income Tax Expense
3204000
Quarters > 3 > income Statement > EBITDA
-3150938
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
49350
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
3161570
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
3533888
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
3533888
Quarters > 3 > balance Sheet > payables
808011
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1972794
Quarters > 3 > balance Sheet > equity
1561094
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-3150938
Quarters > 3 > cash Flow > depreciation
3200000
Quarters > 3 > cash Flow > change In Working Capital
207509
Quarters > 3 > cash Flow > cash From Operations
-2913614
Quarters > 3 > cash Flow > capital Expenditures
4
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-68568
Quarters > 3 > cash Flow > net Change In Cash
-2982182
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-20.26326688102894
Quarters > 3 > ratios > PB
0.001753129536081748
Quarters > 3 > ratios > ROE
-201.84165719681198
Quarters > 3 > ratios > ROA
-89.16349357987576
Quarters > 3 > ratios > FCF
-2913618
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
32
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
12513242
Annuals > 0 > income Statement > operating Income
-12513242
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-12287461
Annuals > 0 > income Statement > net Income
-12287461
Annuals > 0 > income Statement > eps
-80.31020261437908
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
153000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-12287461
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
225781
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
3161570
Annuals > 0 > balance Sheet > short Term Investments
3158408430
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
3533888
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
3533888
Annuals > 0 > balance Sheet > payables
808011
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1972794
Annuals > 0 > balance Sheet > equity
1561094
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-12287461
Annuals > 0 > cash Flow > depreciation
12513000
Annuals > 0 > cash Flow > change In Working Capital
466864
Annuals > 0 > cash Flow > cash From Operations
-11162948
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
6886383
Annuals > 0 > cash Flow > net Change In Cash
-4276565
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-80.31020261437908
Annuals > 0 > ratios > PB
0.002361997419758195
Annuals > 0 > ratios > ROE
-787.1057732590094
Annuals > 0 > ratios > ROA
-347.70374726080735
Annuals > 0 > ratios > FCF
-11162948
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
23
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
8042000
Annuals > 1 > income Statement > operating Income
-8042000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-7795000
Annuals > 1 > income Statement > net Income
-7795000
Annuals > 1 > income Statement > eps
-399.8256052523595
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
19496
Annuals > 1 > income Statement > income Tax Expense
-8041.91
Annuals > 1 > income Statement > EBITDA
247216
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
247216
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
7438135
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
8356
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
7978634
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
7978634
Annuals > 1 > balance Sheet > payables
866028
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1623616
Annuals > 1 > balance Sheet > equity
6355018
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-7794690
Annuals > 1 > cash Flow > depreciation
8042000
Annuals > 1 > cash Flow > change In Working Capital
863677
Annuals > 1 > cash Flow > cash From Operations
-6408931
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
7605772
Annuals > 1 > cash Flow > net Change In Cash
1196841
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-399.8256052523595
Annuals > 1 > ratios > PB
0.00007393426737737014
Annuals > 1 > ratios > ROE
-122.65897594625224
Annuals > 1 > ratios > ROA
-97.69842807678609
Annuals > 1 > ratios > FCF
-6408931
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
9674486
Annuals > 2 > income Statement > operating Income
-9674486
Annuals > 2 > income Statement > interest Expense
63573
Annuals > 2 > income Statement > pretax Income
-9610913
Annuals > 2 > income Statement > net Income
-9610913
Annuals > 2 > income Statement > eps
-139.15548895259607
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
69066
Annuals > 2 > income Statement > income Tax Expense
-9674.49
Annuals > 2 > income Statement > EBITDA
-9674486
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
63573
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
6241294
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
12602
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
6944488
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
6944488
Annuals > 2 > balance Sheet > payables
496702
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
922634
Annuals > 2 > balance Sheet > equity
6021854
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-9610913
Annuals > 2 > cash Flow > depreciation
9674.49
Annuals > 2 > cash Flow > change In Working Capital
-153576
Annuals > 2 > cash Flow > cash From Operations
-8834164
Annuals > 2 > cash Flow > capital Expenditures
4
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
4276652
Annuals > 2 > cash Flow > net Change In Cash
-4557512
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-139.15548895259607
Annuals > 2 > ratios > PB
0.0002764083287306534
Annuals > 2 > ratios > ROE
-159.60056487586712
Annuals > 2 > ratios > ROA
-138.396279178537
Annuals > 2 > ratios > FCF
-8834168
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
7856864
Annuals > 3 > income Statement > operating Income
-7856864
Annuals > 3 > income Statement > interest Expense
45613
Annuals > 3 > income Statement > pretax Income
-7902477
Annuals > 3 > income Statement > net Income
-7948090
Annuals > 3 > income Statement > eps
-152.69225596987687
Annuals > 3 > income Statement > dividends Per Share
2293199
Annuals > 3 > income Statement > shares Outstanding
52053
Annuals > 3 > income Statement > income Tax Expense
45613
Annuals > 3 > income Statement > EBITDA
-7842738
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-45613
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
10798806
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
11623939
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
11623939
Annuals > 3 > balance Sheet > payables
515245
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1516836
Annuals > 3 > balance Sheet > equity
10107104
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-7902477
Annuals > 3 > cash Flow > depreciation
14126
Annuals > 3 > cash Flow > change In Working Capital
289551
Annuals > 3 > cash Flow > cash From Operations
-5693392
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
15961798
Annuals > 3 > cash Flow > net Change In Cash
10268406
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-152.69225596987687
Annuals > 3 > ratios > PB
0.0001241183725822946
Annuals > 3 > ratios > ROE
-78.63864861784346
Annuals > 3 > ratios > ROA
-68.37690734612424
Annuals > 3 > ratios > FCF
-5693392
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-1.6483778667786375
Valuation > metrics > PB
0.004561913607275773
Valuation > final Score
70
Valuation > verdict
99.5% Undervalued
Profitability > metrics > ROE
-42.725894434032256
Profitability > metrics > ROA
-33.36328555569359
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.28062610508517205
Risk > final Score
80
Risk > verdict
Low
Liquidity > metrics > Current Ratio
11.184622883066073
Liquidity > metrics > Quick Ratio
11.184622883066073
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
80
Prev Risks > 1
80
Prev Risks > 2
50
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:43:40.180Z
Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications. Its lead product candidate is XYNGARI, which is in Phase 3 clinical studies for the treatment of moderate-to-severe acne, as well as completed Phase 1b proof of concept (POC) trial for mild-to-moderate psoriasis. The company is also developing DMT410 that has completed Phase 1b POC trials for the treatment of axillary hyperhidrosis and aesthetic skin conditions. It has a clinical trial collaboration agreement with Revance Therapeutics, Inc. to conduct a multi-center clinical trial to evaluate the topical application of XYNGARI with DAXXIFY, Revance's botulinum toxin type A. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AS&P 500 Profit Beats Draw Worst Stock Price Reaction on Record Bloomberg.com
Read more →Gains Recap: Is DRMAW a play on infrastructure spending - July 2025 Retail & Fast Gain Stock Trading Tips baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Dermata Therapeutics Inc. Warrant
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.